A doctor who travels through two eras

Chapter 502 The United States wants to dig up Lin Sanqi

1961, Dongyue Temple, Capital Infectious Disease Hospital.

It's still hot in Hong Kong, but it's already autumn in Beijing.

Bi Xinglong brought in a bamboo basket of small red fruits and delivered it to the foreign doctor's office.

Professor Anthony looked at the fruit in a strange way:
"Bi, is this a Chinese apple? Why are they so small?"

Other American doctors also gathered around and were curious when they saw the basket of apples.

Carol, a female researcher, took a small apple in her palm and happily made a "yeah" gesture.

Bi Xinglong explained with a smile:
"Professor, this is a kind of fruit from our Peking. Its scientific name is crabapple. It can only be eaten in autumn. It was specially sent by the Foreign Affairs Department. We want you to taste it."

In the autumn of 1961, fruits were a rare commodity, and crabapples were definitely treated like state guests.

Professor Anthony took a crab apple and took a bite: "Hmm, sour and sweet, very delicious."

Professor Theodore, who lost 500 million US dollars, had no appetite to eat the shitty fruit. He pulled his hair madly:
"Bi, when will your Dean Lin come back? He has been gone for more than a month. Does he no longer want this hospital? This is too irresponsible. Did he run away with my money?"

Bi Xinglong rolled his eyes in his heart, but still explained with a smile on his face:
"Professor, our Dean Lin went to Hong Kong for an academic conference and is now on his way back to the capital. If you have any needs, please let me know."

Professor Anthony smiled:
"Bi, we have been in your hospital for almost half a year. It is time to return home, so we would like to meet with Dean Lin before we leave. Please send another telegram to urge Lin."

Bi Xinglong nodded gently: "Okay, then I will go to the post office to send an urgent telegram now."

"Thank you for your help. Thank you very much."

"You're welcome!"

After Bi Xinglong left the small conference room, the Harvard Medical School team continued their previous discussion.

Assistant Blake opened his notebook and continued to report:

"Currently, our team has seen a total of 6 patients in the past six months, an average of more than 8000 patients per week. We are responsible for an inpatient department with 300 inpatients.

We received 1500 patients in the first month. According to our team's personal follow-up visits and patient follow-up visits, as of yesterday, the tuberculosis cure rate has reached an astonishing 96%.

In the second month, the same number of patients was seen, and 1600% were cured, probably because the treatment course was one month shorter. Similarly, in the third month, the cure rate was 89%, and in the fourth month, the cure rate dropped to 70%.

Judging from this cure rate curve, the anti-tuberculosis treatment invented by China can be confirmed to have a cycle of 4 to 6 months, which is consistent with President Lin’s previous judgment, and also shows that China has undergone repeated clinical experiments. "

Assistant Clifford continued:

"We have repeatedly tested each patient through sputum culture and chest X-rays. Now we can be very sure that China has indeed completely conquered the treatment of tuberculosis. We can announce that mankind has defeated the world's number one infectious disease."

Professor Theodore slammed the table and cursed: "Fuck, what kind of shit luck does China have!"

Professor Anthony looked at another assistant:
"Austin, you are in charge of drug reverse engineering. After these days of secret research, can you determine the composition of these anti-tuberculosis drugs?"

"Okay, professor. I have reverse engineered the pyridoxine tablets repeatedly. I am now certain that they contain isoniazid and pyrazinamide, and there are two or three other unknown ingredients."

Professor Anthony pondered and said:

"Isoniazid is a patented drug of Roche Pharmaceuticals. Pyrazinamide appeared earlier. I remember it was invented by Kirschner. These two drugs are already on the market. China is producing them without permission. Isn't that an infringement of their patents?" Assistant Austin gave a different opinion:
"It is difficult to determine legally whether there is infringement, because this is a compound preparation with multiple ingredients. The Chinese side has reshuffled the combination and redefined the ethylpyridamole tablet, so it is impossible to determine that they have infringed."

This is also a rule in the medical field, which is equivalent to skirting the rules.

For example, a company invented omeprazole, which is very effective in inhibiting gastric acid and has generated huge economic benefits. What should other companies do if they become jealous?
But they have patent protection, so you can't just sit there and watch this big piece of fat meat without taking a bite, right? That's not capital.

So rabeprazole was invented. It was a structural modification of omeprazole, but the chemical structure, speed of drug efficacy, drug metabolism, acid inhibition strength, and frequency of medication are almost the same.

But you can't say that rabeprazole infringes on the patent of omeprazole.

When other companies saw this, they thought, let’s also take advantage of the loophole, so pantoprazole, esomeprazole, lansoprazole, etc. appeared.

Assistant Austin reminded again:

"I checked through international telegrams and found that the patent for Epyridamole tablets is not in China's hands, but in the hands of a pharmaceutical company in Hong Kong. But strangely, that company is very mysterious. Its registered address is a Chinese medicine clinic. We speculate that it is a shell company in China."

Professor Theodore disagrees:
"It may not be a shell company, because Lin once said that it was the Hong Kong company that commissioned the Chinese side to do the clinical experiment, and the two sides are in a cooperative relationship. If this patent belongs to the Chinese state, I believe they will not allow us Americans to participate."

In fact, people just nodded slightly after hearing this, thinking that there was nothing wrong with the logic.

If China invented an anti-tuberculosis drug and even wrote a paper on it, even if there was nowhere to publish it, it would still be published in the national media.

It's like the fruit is already ripe, how can we allow Americans to come in and interfere?
The only explanation is that the patent for the anti-tuberculosis drug is in the hands of a Xiangjiang company, and Lin Sanqi is the controller of this company.

Thinking of this, Professors Anthony and Theodore looked at each other and saw greed in each other's eyes.

This means that as long as they can get Lin Panax notoginseng, they can not only grab the research project, but also get the drug patent. At worst, they can just throw away their pride and directly modify the Chinese paper and publish it in a top medical journal through connections.

According to the unspoken rules of the medical community, whoever publishes the paper first is the winner.

The core of all this is Lin Sanqi.

Professor Theodore said at this time:

"Although our own experiments have proven that China has indeed conquered tuberculosis, we absolutely cannot accept this conclusion. If Harvard Medical School recognizes this achievement, we will gain nothing and have wasted $500 million."

Assistant Carol joked, "Professor, it should be 1000 million."

This remark hit Professor Theodore's sore spot again, and made him go crazy again:

"Okay, forget about that damn 500 million bet. This is my personal money and it doesn't take up any of our team's funds. What I want to say now is that we have to find a way to lure Lin Sanqi abroad.

Only when he goes abroad can we tempt him with beauties, money, and status, just like other Chinese scientists. After he sees the colorful world in the United States, perhaps he will come to his senses and not want to return to China. "

Assistant Blake pushed up his glasses and offered advice:
"Professor, we can explain it this way. The WHO is composed of various member states. Our Harvard team admits that China's tuberculosis treatment drugs are effective, but it is far from enough because they have not been officially certified.

If China wants to gain international recognition, it needs to go to an internationally renowned hospital or research institute and conduct clinical trials openly in front of the global medical community, with third-party supervision.

China is eager to gain recognition from the international community, and now has only two options. One is to invite infectious disease experts from various countries to gather in China to witness it together. However, given that China is currently being blocked by both the East and the West, this is unlikely.

Then what remains is for the Chinese medical delegation to go abroad and find a hospital recognized by everyone to conduct a new round of clinical verification, such as our Massachusetts General Hospital. To do this, Lin Sanqi, the person in charge, must go to the United States. "

(End of this chapter)